NCT03652636View on ClinicalTrials.gov

Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions

PHASE4CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

August 5, 2019

Primary Completion Date

July 21, 2023

Study Completion Date

July 21, 2023

Conditions
Hepatic Disease
Interventions
DRUG

Sulfur Hexafluoride Microspheres

2.5 mL intravenous injection given at the time of ultrasound, with second 2.5 mL intravenous injection given during ultrasound as needed to improve visualization

Trial Locations (1)

46202

IU University Hospital, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT03652636 - Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions | Biotech Hunter | Biotech Hunter